Report of Foreign Issuer (6-k)
May 23 2016 - 5:01PM
Edgar (US Regulatory)
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of May 2016
Commission File Number: 001-34661
DEHAIER MEDICAL SYSTEMS LIMITED
Dehaier Medical Systems Limited
Room 501, 83 Fuxing Road
Haidian District, Beijing 100856
People’s Republic of China
(Address of principal executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
¨
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
¨
Explanatory Note:
On May 18, 2016, we received a notification letter from the
Listing Qualifications department of the Nasdaq Stock Market stating that because we have not yet filed our Form 20-F for the year
ended December 31, 2015, we are not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of periodic
reports with the Securities and Exchange Commission.
Under the Nasdaq Listing Rules, we have 60 calendar days (until
July 18, 2016) to submit a plan to Nasdaq setting forth how we plan to regain compliance with Nasdaq’s continued listing
requirements. If we are unable to file our Form 20-F by July 18, 2016, then we intend to submit a compliance plan on or prior to
that date.
If we need to submit a compliance plan and Nasdaq accepts our
plan, Nasdaq can grant an exception of up to 180 calendar days from the filing’s due date, or until November 14, 2016, to
regain compliance. If Nasdaq does not accept our plan, we will have the opportunity to appeal that decision to a Nasdaq Hearings
Panel.
On May 20, 2016, we issued a press release announcing our receipt
of the Nasdaq notification letter. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by
reference.
Exhibits
The following document is filed herewith:
Exhibit
Number
|
|
Document
|
|
|
|
99.1
|
|
Press Release dated May 23, 2016.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
DEHAIER MEDICAL SYSTEMS LIMITED
|
|
|
|
May 23, 2016
|
By:
|
/s/ Ping Chen
|
|
|
Ping Chen
|
|
|
Chief Executive Officer
|
|
|
(Principal Executive Officer) and
|
|
|
Duly Authorized Officer
|
Lianluo Smart (NASDAQ:LLIT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Lianluo Smart (NASDAQ:LLIT)
Historical Stock Chart
From Apr 2023 to Apr 2024